The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: A Bayesian coalescent approach

被引:186
作者
Pybus, OG
Drummond, AJ
Nakano, T
Robertson, BH
Rambaut, A
机构
[1] Univ Oxford, Dept Zool, Oxford OX1 2JD, England
[2] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand
[3] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA
关键词
hepatitis C; Egypt; epidemiology; Bayesian inference;
D O I
10.1093/molbev/msg043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) is a leading cause of liver cancer and cirrhosis, and Egypt has possibly the highest HCV prevalence worldwide. In this article we use a newly developed Bayesian inference framework to estimate the transmission dynamics of HCV in Egypt from sampled viral gene sequences, and to predict the public health impact of the virus. Our results indicate that the effective number of HCV infections in Egypt underwent rapid exponential growth between 1930 and 1955. The timing and speed of this spread provides quantitative genetic evidence that the Egyptian HCV epidemic was initiated and propagated by extensive anti schistosomiasis injection campaigns. Although our results show that HCV transmission has since decreased, we conclude that HCV is likely to remain prevalent in Egypt for several decades. Our combined population genetic and epidemiological analysis provides detailed estimates of historical changes in Egyptian HCV prevalence. Because our results are consistent with a demographic scenario specified a priori, they also provide an objective test of inference methods based on the coalescent process.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 43 条
  • [1] ANDERSON R M, 1991
  • [2] Chronic liver disease in the Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infections
    Angelico, M
    Renganathan, E
    Gandin, C
    Fathy, M
    Profili, MC
    Refai, W
    DeSantis, A
    Nagi, A
    Amin, G
    Capocaccia, L
    Callea, F
    Rapicetta, M
    Badr, G
    Rocchi, G
    [J]. JOURNAL OF HEPATOLOGY, 1997, 26 (02) : 236 - 243
  • [3] [Anonymous], MORBIDITY MORTALITY
  • [4] Hepatitis C antibody prevalence in blood donors in different governorates in Egypt
    Arthur, RR
    Hassan, NF
    Abdallah, MY
    ElSharkawy, MS
    Saad, MD
    Hackbart, BG
    Imam, IZ
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (03) : 271 - 274
  • [5] Drummond AJ, 2002, GENETICS, V161, P1307
  • [6] El-Zayadi A, 1999, ITAL J GASTROENTEROL, V31, P472
  • [7] Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4
    ElZayadi, A
    Simmonds, P
    Dabbous, H
    Prescott, L
    Selim, O
    Ahdy, A
    [J]. JOURNAL OF VIRAL HEPATITIS, 1996, 3 (05) : 261 - 264
  • [8] EVOLUTIONARY TREES FROM DNA-SEQUENCES - A MAXIMUM-LIKELIHOOD APPROACH
    FELSENSTEIN, J
    [J]. JOURNAL OF MOLECULAR EVOLUTION, 1981, 17 (06) : 368 - 376
  • [9] The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
    Frank, C
    Mohamed, MK
    Strickland, GT
    Lavanchy, D
    Arthur, RR
    Magder, LS
    El Khoby, T
    Abdel-Wahab, Y
    Ohn, EA
    Anwar, W
    Sallam, I
    [J]. LANCET, 2000, 355 (9207) : 887 - 891
  • [10] Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect
    Gad, A
    Tanaka, E
    Orii, K
    Rokuhara, A
    Nooman, Z
    Serwah, AH
    Shoair, M
    Yoshizawa, K
    Kiyosawa, K
    [J]. JOURNAL OF GASTROENTEROLOGY, 2001, 36 (11) : 753 - 758